Skip to content

Renault to Bolster Robotics Through Venture Capital Support for Start-up

Renault Intends to Augment Robotics with Venture Capital Into Start-Up Company

Renault Plans to Propel Robotics Development Through Venture Capital Investment in a Start-Up
Renault Plans to Propel Robotics Development Through Venture Capital Investment in a Start-Up

Renault to Bolster Robotics Through Venture Capital Support for Start-up

Renault and Wandercraft Partner to Develop Next-Generation Robots and Exoskeletons

Renault Group has made a minority investment in French start-up Wandercraft, a specialist in robotics, marking the beginning of a commercial partnership to co-develop a family of next-generation industrial robots. This collaboration, which is part of Renault's strategic move towards automation and industry-specific robotics, aims to enhance worker safety and production efficiency.

The partnership between the two companies, as announced on Autoline Daily's 2025 Top Industry News for August 1, will see Renault assisting Wandercraft in scaling up production and industrializing robots and medical exoskeletons. One of the anticipated outcomes is the launch of Wandercraft's upcoming exoskeleton "Eve," scheduled for 2026.

Thierry Charvet, chief industry and quality officer for Renault, stated that the partnership is expected to advance business operations for both companies. Charvet indicated that the benefits of the partnership extend to both Renault and Wandercraft, with potential cost reductions through design-to-cost and scaling using Renault's automotive expertise. He also predicted that the partnership would drive productivity through the acceleration of production time.

The partnership is not limited to the Calvin family of next-generation robots. It could potentially impact other areas of robotics as well. Wandercraft specializes in developing, manufacturing, and marketing medical self-balancing exoskeletons. This partnership could open new business opportunities in robotics for Wandercraft, particularly in the industrial sector.

Further details reveal that Wandercraft secured $75 million in Series D funding, with Renault Group participating as both an investor and a partner to accelerate the launch of "Eve," expand clinical adoption of their rehabilitation exoskeleton Atalante X, and advance industrial development of the humanoid robot Calvin-40. This funding round also involved participation from French public funds, indicating strong support for Robotic innovation in mobility and industry sectors.

In summary, Renault's latest steps focus on jointly developing and industrializing next-generation industrial robots and exoskeletons with Wandercraft, leveraging their technological expertise to improve production ergonomics and efficiency while expanding Wandercraft's market reach in industrial and medical robotics. The project is expected to reduce production time and increase productivity for Renault, with Charvet also predicting that the partnership will result in costs reduction.

The strategic partnership between Renault and Wandercraft evolves beyond next-generation industrial robots, as it may also influence technology advancements in the finance sector, considering the potential cost reductions through design-to-cost and scaling using Renault's automotive expertise. Moreover, the collaboration's focus on industrializing robots could extend to technology improvements in the vehicle production industry, with anticipation for the launch of Wandercraft's upcoming exoskeleton, "Eve."

Read also:

    Latest